Skip to content

Insider · CIK 0001720568

Patrick D Walsh

director

Files at ANIP (ANI PHARMACEUTICALS INC). First filing Aug 18, 2025, latest Nov 17, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $1.6M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ANIP: ANI PHARMACEUTICALS INC

ANIPOct 9, 2026 · close 73.89

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
57Moderate
ANIPsell 3
ANI PHARMACEUTICALS INC
$751k
8,643 shares
-12%+58% from low-14% from high
57Moderate
ANIPsell 13
ANI PHARMACEUTICALS INC
$801k
9,000 shares
-11%+64% from low-3% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 13, 2025ANIP
ANI PHARMACEUTICALS INC
SOpen-market sale
Common Stock
-8,643$86.88$751k61,405Nov 17, 2025
Nov 13, 2025ANIP
ANI PHARMACEUTICALS INC
GGift
Common Stock
-3,000$0.00$058,405Nov 17, 2025
Aug 15, 2025ANIP
ANI PHARMACEUTICALS INC
SOpen-market sale
Common Stock
-9,000$89.05$801k70,048Aug 18, 2025
May 22, 2025ANIP
ANI PHARMACEUTICALS INC
AGrant or award
Common Stock
+4,336$0.00$079,048May 27, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Patrick D Walsh: insider trades and track record | InsiderTell